Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Introduction<p>Although the transcatheter arterial chemoembolization (TACE) combined with sintilimab and bevacizumab improves outcomes in unresectable HCC (uHCC), predictive tools are lacking. This study developed and validated a prognostic model for triple therapy efficacy.</p>Methods&l...

全面介绍

Saved in:
书目详细资料
主要作者: Liying Ren (11143129) (author)
其他作者: Dongbo Chen (10430738) (author), Xue Zhang (166886) (author), Shaoping She (22678979) (author), Ran Fei (93650) (author), Xu Cong (159269) (author), Shaowei Mu (22678982) (author), Yuchen Zhou (1601536) (author), Jie Gao (10266) (author), Weijia Liao (492662) (author), Hongsong Chen (159274) (author)
出版: 2025
主题:
Genetic Immunology
hepatocellular carcinoma
immunotherapy
transcatheter arterial chemoembolization
prognostic model
FAAP score
标签: 添加标签
没有标签, 成为第一个标记此记录!
成为第一个发表评论!
您必须先登录

相似书籍